Dbct - Dihydrolipoamide branched chain transacylase E2
Predicted to enable acetyltransferase activity and lipoic acid binding activity. Predicted to contribute to branched-chain alpha-keto acid dehydrogenase activity. Involved in L-leucine catabolic process; isoleucine catabolic process; and valine catabolic process. Predicted to be part of branched-chain alpha-ketoacid dehydrogenase complex. Predicted to be active in mitochondrion. Is expressed in adult head; adult heart; embryonic/larval midgut; and organism. Used to study maple syrup urine disease. Human ortholog(s) of this gene implicated in maple syrup urine disease. Orthologous to human DBT (dihydrolipoamide branched chain transacylase E2). [provided by Alliance of Genome Resources, Dec 2024]
NCBI Orthologs
How was this calculated?genes for:
Protein alignment
Download data
Species | Gene | Architecture | aa |
---|